Corticosteroid therapy. Updating of principles.
D000284:Administration, Oral; D000287:Administration, Topical; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D002648:Child; D003128:Coma / Q000139:chemically induced; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D005059:Euphoria / Q000139:chemically induced; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006207:Half-Life; D006801:Humans; D007031:Hypothalamus / Q000502:physiology; D007263:Infusions, Parenteral; D009132:Muscles / Q000187:drug effects; D010902:Pituitary Gland / Q000502:physiology; D011559:Pseudotumor Cerebri / Q000139:chemically induced; D013329:Structure-Activity Relationship; D013375:Substance Withdrawal Syndrome; D013997:Time Factors
D005938:Glucocorticoids; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone